The PAR proteins have an essential and conserved function in establishing polarity in many cell types and organisms. However, their key upstream regulators remain to be identified. In C. elegans, regulators of the PAR proteins can be identified by their ability to suppress the lethality of par-2 mutant embryos. Here we show that a nos-3 loss of function mutant suppresses the lethality of par-2 mutants by regulating PAR-6 protein levels. The suppression requires the activity of the sex determination genes fem-1/2/3 and of the cullin cul-2. FEM-1 is a substrate-specific adaptor for a CUL-2-based ubiquitin ligase (CBC FEM-1 ). Interestingly, we find that CUL-2 is required for the regulation of PAR-6 levels and that PAR-6 physically interacts with FEM-1. Our data strongly suggest that PAR-6 levels are regulated by the CBC FEM-1 ubiquitin ligase thereby uncovering a novel role for the FEM proteins and cullin-dependent degradation in regulating PAR proteins and polarity processes.
Introduction
Cell polarity is a property of many cells important for processes such as differentiation and morphogenesis. In particular, establishment of a polarity axis is an essential prerequisite for asymmetric cell division, a fundamental process that generates cell diversity during the development of metazoans (Betschinger and Knoblich, 2004) . Work in several model organisms demonstrated that the conserved PAR (partitioning-defective) proteins play a fundamental role in establishing and maintaining polarity in many cell types, including asymmetrically dividing cells but also nondividing cell types (Suzuki and Ohno, 2006) .
The C. elegans embryo is an excellent model system to study establishment of a polarity axis and asymmetric cell division. The first division of the embryo is asymmetric resulting in two cells that are different in size and fate. This asymmetric division relies on the establishment of an antero-posterior polarity axis in the one-cell embryo. Proper establishment of this axis requires the PAR proteins (PAR-1 to -6 and PKC-3) (Kemphues et al., 1988; Suzuki and Ohno, 2006 ). In the one-cell embryo, PAR proteins define an anterior and a posterior cortical domain: PAR-3 and PAR-6, two PDZ containing proteins, and PKC-3, an atypical protein kinase C, are localized at the anterior cortex of the embryo (Etemad-Moghadam et al., 1995; Hung and Kemphues, 1999; Tabuse et al., 1998a) , while PAR-1, a serinethreonine kinase, and PAR-2, a ring finger containing protein, are restricted to the posterior cortex Guo and Kemphues, 1995) .
Although the essential function of PAR proteins in establishing polarity is conserved, the mechanisms controlling PAR protein levels and asymmetric distribution are still not fully understood. In the early C. elegans embryo, asymmetric localization of PAR proteins occurs in two steps (Cuenca et al., 2003) . First, anteriorly directed cortical flows result in the accumulation of PAR-3, PAR-6 and PKC-3 at the anterior cortex (Cheeks et al., 2004; Cowan and Hyman, 2007; Munro et al., 2004) . Second, accumulation of PAR-2 at the posterior cortex maintains this asymmetric distribution of the anterior PARs (Cheeks et al., 2004; Cuenca et al., 2003; Hao et al., 2006) .
In par-2 mutant embryos the anterior PAR proteins spread towards the posterior, leading to polarity defects and embryonic lethality (Etemad-Moghadam et al., 1995; Hung and Kemphues, 1999; Kemphues et al., 1988; Tabuse et al., 1998b) . Interestingly, reduction of PAR-6, PAR-3 or PKC-3 levels in a par-2 mutant background is sufficient to suppress par-2 polarity defects and lethality (Labbe et al., 2006; Watts et al., 1996) . We recently found that a nos-3 mutant, nos-3(q650), suppresses par-2(it5) lethality and polarity defects and restores the asymmetric localization of PAR-3 and PAR-6 (Labbe et al., 2006) . nos-3 is one of the three C. elegans homologues of Nanos, a translational repressor involved in establishing the antero-posterior axis in early Drosophila embryos (Wang and Lehmann, 1991) . In C. elegans, NOS-3 has been proposed to repress the translation of fem-3, a gene involved in sex deter-mination (Hodgkin, 1986; Kraemer et al., 1999) . Here we show that the suppression of par-2(it5) phenotypes in nos-3(q650);par-2(it5) embryos requires the activity of the sex determination factors FEM-1/2/3. Recently, FEM-1 has been shown to be a substratespecific adaptor for a CUL-2/ElonginB/C based ubiquitin ligase referred to as CBC FEM-1 , for the components CUL-2, Elongin B and Elongin C (Kamura et al., 2004; Starostina et al., 2007) . Consistent with this, cul-2 is also required for the suppression of par-2(it5) by nos-3(q650). Interestingly we find that NOS-3 suppresses par-2 phenotypes by regulating PAR-6 levels in a CUL-2 dependent manner. Together with the observation that the substrate-specific adaptor FEM-1 physically interacts with PAR-6, our data strongly suggest that the CBC FEM-1 ubiquitin ligase negatively regulates PAR-6 by promoting its degradation.
Materials and methods

Strains
The wild-type strain was the N2 (Bristol) strain. The alleles used in this study were LGII: nos-3(q650) (Kraemer et al., 1999) ; LGIII: par-2(it5ts) (Kemphues et al., 1988) ;
LGIV: fem-3(e2006) (Hodgkin, 1986) . For the pie-1::GFP::PAR-6 transgene, PAR-6 cDNA was cloned into pID3.01 (Pellettieri et al., 2003) . All strains were maintained at 15°C as described except the nos-3(q650);GFP::PAR-6 strain which was maintained at 22°C.
RNAi and suppression assays par-2, fem-1 and fem-2 RNAi constructs are as previously described (Kamath et al., 2003) . cul-2 and fem-3 RNAi constructs were obtained from L. Pintard and C. Eckmann. For all RNAi constructs the genes were cloned into the L4440 vector (Timmons and Fire, 1998) .
Embryonic lethality was assessed 24 h after removing adult worms from plates, dividing the number of nonhatched embryos by the total number of progeny.
Since we could not obtain a par-2(it5);GFP::PAR-6 strain, inactivation of par-2 in nos-3(q650);GFP::PAR-6 was done by injecting par-2 dsRNA in nos-3(q650);GFP:: PAR-6. Adult worms were grown at 22°C, singled 24 h and removed 48 h postinjection. Analysis of nos-3(q650);par-2(it5);fem-3(e2006) triple mutants was done by shifting L4 larvae to 25°C. fem-1, fem-2 and fem-3 RNAi was performed by injection. Adult worms were grown at 25°C, singled 18 h and removed 48 h post-injection. For cul-2(RNAi) experiments L1 larvae were grown on OP50 for 60 h at 15°C and then shifted to 20°C. After 72 h worms were washed and transferred to feeding plates (1 mM IPTG). Worms were removed after 83 h.
The experiments in each panel were performed in parallel and with the same conditions.
Microscopy DIC time-lapse images were acquired by an Orca ER Hamamatsu CCD camera, mounted on a Zeiss Axiovert 200 microscope. Images were acquired at 10 s intervals using the Openlab software (Improvision Ltd.).
For immunofluorescence analysis, embryos were fixed in methanol and stained according to standard procedures with rabbit anti-PAR-6 antibodies (Labbe et al., 2006) and Alexa568-coupled goat-anti-rabbit secondary antibodies (Molecular Probes). Images were acquired using a Leica SP2 confocal microscope.
Western blot analysis nos-3(q650) and nos-3(q650);GFP::PAR-6 worms were grown at 25°C. For control (L4440) and cul-2 RNAi in N2 and nos-3(q650), L1 larvae were grown for 24 h at 25°C on NA22, washed and transferred on 1 mM IPTG feeding plates for 27 h.
Embryos were collected by bleaching adult hermaphrodites, resuspended in SDSsample buffer and heated 5 min at 95°C. The following antibodies were used: rabbit anti-PAR-6 and anti-PAR-3 (Labbe et al., 2006) , rabbit anti-PKC-3 (raised to aa 1 to 229 of PKC-3 fused to GST), mouse anti-tubulin (DM1A, Roche), mouse anti-HA (HA.11, Covance), mouse anti-Flag (M2, Sigma) and secondary antibodies coupled to HRP (Bio-Rad). To measure protein amounts semi-quantitatively, films were scanned and signal intensity measured with the Quantity One software (Bio-Rad). Total signal intensities of nonsaturated bands were measured and the background subtracted. The ratio PAR/ tubulin was normalized to 100 in control samples. For Figs. 4A-C, results were obtained from 4 independent extracts and 9 blots. For Fig. 6 , experiments were performed in parallel and results were obtained from 2 independent extracts and 6 blots.
Cell culture, transfections, immunoprecipitations
For expression in Drosophila S2 cells, C. elegans par-6 cDNA was cloned into pAc5.1 (Invitrogen), fem-1, fem-2, fem-3 and mex-5 cDNAs into pAHW and pAFW (Drosophila Gateway Vector Collection, N-terminal HA-tag). For immunoprecipitations, S2 cells were transfected with the FuGENE 6 reagent 48 h before cell extraction and, for Figs. 7A, B, incubated 6 h with proteasome inhibitor (MG132, 50 μM). Extracts were performed in 20 mM Tris pH 7.5, 100 mM NaCl, 5 mM MgCl 2, 0.2% NP40, 10% glycerol, 1 mM NaF, 20 mM β-glycerophosphate, 0.5 mM DTT and Complete Protease Inhibitor (Roche). Immunoprecipitations were performed with anti-PAR-6 antibody (Labbe et al., 2006) (Figs. 7A, B ) or anti-HA antibody ( Fig. 2A) , and protein A beads (Biorad). Beads were preincubated with antibody for 2 h, incubated 2 h with cell extracts and washed with TBS-Tween-20 (0.05%) and IP buffer (20 mM Tris pH 7.5, 150 mM NaCl, 5 mM MgCl 2 , 0.1% NP40, 5% glycerol, 20 mM β-glycerophosphate, 0.5 mM DTT and Complete Protease Inhibitor (Roche)). (q650) is strongly inhibited in nos-3(q650);par-2(it5);fem-3(e2006) triple mutant. Embryonic lethality was assessed by counting more than 500 progeny of each genotype. (B) In wild-type 2-cell embryos, the anterior blastomere (AB) is bigger than the posterior blastomere (P1), AB and P1 divide asynchronously, the nucleo-centrosomal complex rotates in P1, which results in the AB and P1 mitotic spindles being perpendicular to each other, and PAR-6 is localized at the cortex of AB. In par-2(it5) embryos, AB and P1 have the same size, divide synchronously, nucleo-centrosomal complex rotation in P1 does not occur and PAR-6 is localized at both AB and P1 cortices. Asymmetry in size was evaluated by measuring AB length/total embryo length ratio after completion of the first cytokinesis. Delay between AB and P1 cytokinesis in par-2(it5) mutants ranged from 0 to 60 s. Division was considered asynchronous when the delay between AB and P1 cytokinesis was higher than 60 s. Position of the P1 spindle was measured just after nuclear envelope breakdown, alignment along the antero-posterior axis corresponds to 0°. On the graph, one short bar represents one embryo. The length of each bar is proportional to the number of embryos scored for a given angle. Anterior is to the left. Arrowheads in the DIC images indicate the spindle poles. n is the number of embryos analyzed.
In vitro binding assay
For the in vitro binding assay, fem-1, zif-1 and mex-5 cDNAs were cloned into pDEST-15 (Invitrogen, N-terminal GST fusion). The HIS-PAR-6 construct was described in Hung and Kemphues (1999) . GST-FEM-1, GST-ZIF-1, GST-MEX-5 and HIS-PAR-6 were expressed in the C41 E. Coli strain grown in LB + 150 mM NaCl and 5% Glycerol and induced with 0.5 mM IPTG (4 h at 16°C). Bacteria expressing GST-tagged proteins were lysed in 50 mM Tris pH7.5, 500 mM NaCl, 0.05% NP40, 2 mM DTT, 1 mM EDTA, 10% glycerol and protease cocktail inhibitor (Roche). Lysates were incubated overnight with glutathione sepharose 4B beads at 4°C. Bound proteins were washed 5 times in the same buffer. Bacteria expressing HIS-PAR-6 were lysed in 50 mM NaH 2 PO 4 , pH 8, 300 mM NaCl, 0.05% NP-40, 2 mM DTT and protease cocktail inhibitor (Roche). Lysates were incubated with Ni-NTA agarose in lysis buffer + 10 mM imidazole, the resin was then washed in lysis buffer + 20 mM imidazole and HIS-PAR-6 eluted in lysis buffer + 150 mM imidazole. Binding was performed with 1 μg of each protein, in 50 mM Tris pH7.5, 150 mM NaCl, 0.5% Triton, 2 mM DTT, 1 mM EDTA, 10% glycerol and protease cocktail inhibitor (Roche), 1 h at room temperature. Beads were washed 5 times in the same buffer before adding sample buffer.
Results
We previously showed that loss of NOS-3 is able to suppress par-2(it5) lethality and polarity defects (Labbe et al., 2006 and Figs. 1A, B) . We next sought to determine the mechanisms by which nos-3(q650) suppresses par-2(it5) phenotypes. In the C. elegans germline, NOS-3 has been proposed to repress the translation of fem-3, a gene involved in sex determination (Hodgkin, 1986; Kraemer et al., 1999) . We therefore tested whether the suppression of par-2(it5) phenotypes in nos-3(q650);par-2(it5) embryos depends on fem-3. Indeed, suppression of par-2(it5) lethality was strongly reduced in nos-3(q650);par-2(it5);fem-3(e2006) mutants (Fig. 1A) . In addition, the suppression of par-2(it5) polarity defects was also reduced in nos-3(q650);par-2(it5);fem-3(e2006) when compared to nos-3 (q650);par-2(it5) embryos ( Fig. 1B and legend) . Moreover, FEM-3 is also required to restore the asymmetric localization of PAR-6 in nos-3(q650);par-2(it5) embryos (Fig. 1B) . These data are consistent with NOS-3 acting as a repressor of fem-3 and shows that FEM-3 is required for the suppression of par-2(it5) phenotypes.
In the germline, two other fem genes, fem-1 and fem-2, behave genetically like fem-3 (Hodgkin, 1986) . Consistently, FEM-1, FEM-2 and FEM-3 form a complex ( Fig. 2A and Starostina et al., 2007) and are components of the CUL-2/ElonginB/C based ubiquitin ligase CBC FEM-1 (Starostina et al., 2007) . We therefore asked whether the CBC FEM-1 ubiquitin ligase was required for the suppression of par-2(it5) phenotypes by nos-3(q650). We inactivated fem-1 and fem-2 by RNAi and found that RNAi to both fem-1 and fem-2 inhibits the suppression of par-2(it5) embryonic lethality by nos-3(q650) (Figs. 2B, C and legend for statistical analysis). Unfortunately we did not obtain triple mutants with fem-1ts and fem-2ts mutant alleles. However, although the effect of depleting fem-1 and fem-2 by RNAi was weaker than the effect observed with the fem-3(e2006) mutant (Fig. 1A) , it was comparable to the effect observed with fem-3(RNAi) (Fig. 2D ). Furthermore, cul-2 behaves genetically similarly to the fem genes: weak inactivation of cul-2 by RNAi that did not increase the embryonic lethality of nos-3(q650) was sufficient to inhibit the suppression of par-2(it5) lethality by nos-3(q650) (Fig. 3A) . The suppression of par-2(it5) polarity defects is also reduced in nos-3(q650);par-2(it5) cul-2(RNAi) embryos compared to nos-3(q650);par-2(it5) embryos (Fig. 3B ). This effect is specific to cul-2 since RNAi to cul-1 or cul-3 did not inhibit suppression of par-2(it5) lethality by nos-3(q650) mutants (data not shown). Altogether, these results indicate that the -1 (B) , fem-2 (C), fem-3 (D) by RNAi leads to significant increased lethality of nos-3(q650);par-2(it5) embryos (student t-test p b 0.05) but not to increased lethality of nos-3(q650). The difference between the lethality of par-2(it5) and par-2(it5);fem-1(RNAi) or par-2(it5)fem-2(RNAi) is not significant. Lethality was assessed by counting more than 500 progeny of each genotype. CBC FEM-1 ubiquitin ligase is required for the suppression of par-2 (it5) phenotypes by nos-3(q650).
Reducing the levels of the anterior PAR proteins has been shown to suppress par-2 phenotypes (Labbe et al., 2006; Watts et al., 1996) . Moreover, our data show that the suppression of par-2(it5) phenotypes by nos-3(q650) requires CUL-2, raising the possibility that the suppression of par-2(it5) phenotypes by nos-3(q650) may be due to the CUL-2 dependent degradation of one of the anterior PAR proteins. We therefore tested whether the levels of the anterior PAR proteins were reduced in nos-3(q650) embryos. Interestingly, western blot analysis showed that PAR-6 levels were reduced in nos-3(q650) embryos compared to wild-type embryos (Fig. 4A ). Neither PKC-3 nor PAR-3 levels were significantly reduced in nos-3(q650) embryos (Figs. 4B, C). Therefore, NOS-3 positively regulates PAR-6 levels but not PKC-3 and PAR-3 levels.
nos-3(q650) embryos have about half of the wild-type PAR-6 levels (Fig. 4A ), but no obvious polarity defects (Labbe et al., 2006) , showing that this reduction of PAR-6 levels is not sufficient to result in par-6 phenotypes. Consistently, we also did not observe obvious polarity defects in embryos from par-6(zu222+/−) heterozygous hermaphrodites (data not shown). However, like in par-6 heterozygous mutants, which also suppress par-2 lethality (Watts et al., 1996) , the reduction of PAR-6 levels in nos-3(q650) mutants is most likely responsible for the suppression of par-2(it5) lethality. To test this, we inactivated par-2 in a strain mutant for nos-3 but expressing higher total levels of PAR-6 protein, resulting from the expression of both endogenous PAR-6 and GFP::PAR-6 (nos-3(q650);pie-1::GFP::PAR-6) (Fig. 5B) . While embryonic lethality of par-2(RNAi) was strongly suppressed in nos-3(q650) mutants, no significant suppression was observed in nos-3(q650);GFP::PAR-6 embryos (Fig. 5A ). Although we cannot exclude that regulation of other polarity factors by nos-3 also contributes to the suppression of par-2 lethality, this result indicates that the suppression is mainly due to the reduction of PAR-6 levels observed in nos-3(q650) embryos.
Suppression of par-2(it5) lethality by nos-3(q650) mutants requires both CUL-2 and reduction of PAR-6 levels, suggesting that PAR-6 may be degraded in a CUL-2 dependent manner. We therefore tested whether the reduction of PAR-6 levels in nos-3(q650) mutants was dependent on CUL-2. Since cul-2(RNAi) embryos have early embryonic defects (Liu et al., 2004; Sonneville and Gonczy, 2004) they cannot directly be compared to control embryos. However, we find that while PAR-6 levels are reduced in nos-3(q650) compared to wild-type embryos, they are equal in nos-3(q650) and wild-type when cul-2 is inactivated (Fig. 6 ). This indicates that CUL-2 is required for the reduction of PAR-6 levels in nos-3(q650) mutants and suggests that PAR-6 can be degraded in a CUL-2 dependent manner.
To determine whether PAR-6 could be a direct substrate of the CBC FEM-1 ubiquitin ligase, we tested whether PAR-6 interacts with FEM-1, which has been shown to be the substrate-specific adaptor for CBC FEM-1 . When coexpressed in Drosophila S2 cells, FEM-1 co- Fig. 3 . CUL-2 is required for the suppression of par-2(it5) lethality by nos-3(q650). (A) Inactivation of cul-2 by RNAi leads to significant increased lethality of nos-3(q650); par-2(it5) embryos (student t-test p b 0.05) but not to increased lethality of nos-3(q650). Lethality was assessed by counting more than 500 progeny of each genotype. (B) cul-2(RNAi) inhibits the suppression of par-2(it5) polarity defects such as symmetry of division and absence of nucleo-centrosomal complex rotation in P1 by nos-3(q650). Asynchrony of division is similar in nos-3(q650);par-2(it5) and nos-3(q650);par-2(it5) cul-2(RNAi) embryos. Asymmetry in size, asynchrony of division and orientation of the P1 spindle were measured as in Fig. 1B . Anterior is to the left. Fig. 4 . PAR-6 protein levels are reduced in nos-3(q650) embryos. (A-C) PAR-6 (A), but not PKC-3 (B) and PAR-3 (C), levels are lower in nos-3(q650) than in wild-type embryos (student t-test between wild-type and nos-3(q650) for PAR-6 p b 0.001, for PKC-3 and PAR-3 p N 0.1). immunoprecipitated with PAR-6 but was not recovered in immunoprecipitates from control cells which did not express PAR-6 ( Fig. 7A ). An unrelated protein, MEX-5, did not co-immunoprecipitate with PAR-6 ( Fig. 7A) . Interestingly, FEM-3 and weakly FEM-2, also coimmunoprecipitated with PAR-6 and FEM-1 (Fig. 7B ). Bacterially purified GST-FEM-1 was also able to interact in vitro with bacterially purified HIS-PAR-6, while two other proteins, GST-MEX-5 (not shown) and another CUL-2 substrate-specific adaptor, GST-ZIF-1 (Fig. 7C) were not able to interact with PAR-6 in the same conditions. Altogether our data suggest that PAR-6 is a substrate of the CBC FEM-1 ubiquitin ligase.
Discussion
Here we show that nos-3(q650) suppresses par-2(it5) lethality by controlling PAR-6 levels. Our data also show that the suppression of par-2(it5) phenotypes by nos-3(q650) requires FEM-1/2/3 and CUL-2. Moreover, we find that CUL-2 is required for the regulation of PAR-6 levels and that PAR-6 interacts with the substrate-specific adaptor FEM-1, suggesting that PAR-6 is a substrate of the CBC FEM-1 ubiquitin ligase.
Previous data suggested that NOS-3 represses fem-3 translation by binding to the PUMILIO homologues, FBF-1 and FBF-2 (Kraemer et al., 1999) . We recently showed that fbf-1 and fbf-2 are also par-2 suppressors (Labbe et al., 2006) and we find here that the suppression of par-2(it5) phenotypes by nos-3(q650) requires the activity of fem-3. Altogether, these data suggest that NOS-3 suppresses par-2(it5) phenotypes by repressing fem-3 translation (Fig. 7D) .
Work from the Kipreos lab has shown that FEM-3 forms a complex with FEM-1, FEM-2 and the cullin CUL-2. FEM-1 has been shown to be a substrate-specific adaptor for the CUL-2/ElonginB/C based ubiquitin ligase CBC FEM-1 while FEM-2 and FEM-3 increase the activity of this ubiquitin ligase when cotransfected in mammalian cells (Starostina et al., 2007) . Here we show that PAR-6 levels are regulated by NOS-3 in a CUL-2 dependent manner. Consistently with PAR-6 regulation occurring at the protein level, par-6 mRNA levels are unchanged in nos-3 mutants (data not shown). Importantly, we also find that the substrate-specific adaptor FEM-1 physically interacts with PAR-6, suggesting that the CBC FEM-1 ubiquitin ligase directly regulates PAR-6 degradation (Fig. 7D ). However, we cannot exclude alternative mechanisms involving indirect regulation of PAR-6 levels by the CBC FEM-1 ubiquitin ligase. For instance CBC FEM-1 could degrade a protein which is in turn essential for PAR-6 stability.
Where and when the regulation of PAR-6 levels occurs is so far not known. One possibility is that the regulation of PAR-6 levels occurs in the germline during late oogenesis. Alternatively, this regulation could (also) occur in the embryo. If regulation of PAR-6 levels occurs in the embryo, it would be of great interest to determine whether PAR-6 regulation is uniform or asymmetric along the antero-posterior axis. Indeed, asymmetric activity of the CBC FEM-1 ubiquitin ligase could contribute to reinforce PAR-6 asymmetric distribution. Notably, CUL-2, together with another substrate-specific adaptor, the protein ZIF-1, has previously been shown to be active in the anterior blastomere of the two-cell stage embryo where it degrades germline proteins (DeRenzo et al., 2003) . This raises the interesting possibility that the asymmetric activity of different substrate-specific adaptors allows CUL-2 to degrade specific substrates preferentially at the anterior or the posterior of the embryo. A third substrate-specific adaptor of CUL-2, ZYG-11, has been shown to participate in polarity establishment by a so far unknown mechanism (Liu et al., 2004; Sonneville and Gonczy, 2004) . This emphasizes that CUL-2, via its different substrate adaptors, regulates polarity of the early C. elegans embryo at multiple levels.
In conclusion, our work shows that PAR-6 levels can be regulated and that this regulation depends on the activity of a CUL-2 based ubiquitin ligase. Thereby our work reveals a novel role for the FEM Fig. 6 . Reduction of PAR-6 protein levels in nos-3(q650) embryos requires CUL-2. (A, B) PAR-6 levels are lower in nos-3(q650) compared to wt embryos but the same in nos-3(q650);cul-2(RNAi) compared to cul-2(RNAi) embryos (student t-test between wt and nos-3(q650) p b 0.001, between cul-2(RNAi) and nos-3(q650) p N 0.1). The experiments in panels A and B were performed in parallel and with the same conditions (see Materials and methods). . Reduction of PAR-6 levels in nos-3(q650) embryos is required for the suppression of par-2 lethality. (A) Increased PAR-6 levels due to the expression of a GFP::PAR-6 transgene inhibit the suppression of par-2 lethality by nos-3(q650). (B) Total PAR-6 protein levels are higher in nos-3(q650);GFP::PAR-6 embryos compared to nos-3(q650) embryos. Endogenous PAR-6 and GFP::PAR-6 were detected with anti-PAR-6 antibody. The downregulation of endogenous PAR-6 levels observed in nos-3(q650);GFP::PAR-6 embryos compared to nos-3(q650) embryos is also observed in GFP::PAR-6 embryos compared to wild-type embryos (data not shown). Bands shown were obtained from nonadjacent lanes of the same blot. proteins and cullin-dependent degradation in regulating PAR proteins and polarity processes.
